Systematic review / meta-analysis / 2023
An umbrella review found berberine significantly affected blood glucose, insulin resistance, lipids, body parameters, and other health outcomes vs. controls.
An umbrella review searched PubMed, Cochrane Library, and Embase through June 30, 2022, to identify meta-analyses of RCTs assessing the efficacy and safety of berberine. Across 11 eligible meta-analyses, berberine significantly affected blood glucose levels, insulin resistance, blood lipids, body parameters and composition, inflammatory markers, colorectal adenomas, and Helicobacter pylori infections compared to controls. Common side effects included gastrointestinal symptoms like constipation and diarrhea. The authors noted that methodological quality in published meta-analyses needs improvement and clinical effects need to be confirmed in high-quality RCTs.
- Study type
- Umbrella review of meta-analyses of RCTs
- Who was studied
- Participants across 11 eligible meta-analyses of RCTs
- What was measured
- Blood glucose, insulin resistance, blood lipids, body parameters/composition, inflammatory markers, colorectal adenomas, H. pylori, and adverse effects
THE PAPER
Berberine and health outcomes: An umbrella review.
Li Z, Wang Y, Xu Q, Ma J, Li X, Yan J, Tian Y, Wen Y, Chen T. Phytother Res, 2023.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.